4121 Stock Overview
Rossmax International Ltd. engages in the development and supply of healthcare products and solutions in Taiwan.
Rossmax International Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NT$21.50|
|52 Week High||NT$34.45|
|52 Week Low||NT$18.30|
|1 Month Change||-9.85%|
|3 Month Change||2.38%|
|1 Year Change||4.88%|
|3 Year Change||67.97%|
|5 Year Change||79.92%|
|Change since IPO||-11.73%|
Recent News & Updates
|4121||TW Medical Equipment||TW Market|
Return vs Industry: 4121 exceeded the TW Medical Equipment industry which returned -8.9% over the past year.
Return vs Market: 4121 exceeded the TW Market which returned -17.6% over the past year.
|4121 Average Weekly Movement||5.6%|
|Medical Equipment Industry Average Movement||5.5%|
|Market Average Movement||5.0%|
|10% most volatile stocks in TW Market||8.2%|
|10% least volatile stocks in TW Market||2.4%|
Stable Share Price: 4121 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 4121's weekly volatility (6%) has been stable over the past year.
About the Company
Rossmax International Ltd. engages in the development and supply of healthcare products and solutions in Taiwan. The company offers activity monitor, a device for monitoring and tracking fitness-related metrics, such as distance walked or run, counting steps, and calories burned; body fat monitors that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listening to the internal sounds; handheld pulse oximeter monitors to measure the amount of oxygen carried in the body; non-contact telephoto thermometers; and blood glucose monitoring system, a medical device for determining the approximate concentration of glucose in the blood. It also provides nebulizer, a drug delivery device used to administer medication; suction unit, a machine used to remove mucus and other bodily fluids; aero spacer, a device used to increase the ease of administering aerosolized medication; peak flow meter, a device used to monitor a person's ability to breathe out air; heating pad for therapy; and anti-decubitus mattresses.
Rossmax International Fundamentals Summary
|4121 fundamental statistics|
Is 4121 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|4121 income statement (TTM)|
|Cost of Revenue||NT$2.78b|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||1.40|
|Net Profit Margin||2.84%|
How did 4121 perform over the long term?See historical performance and comparison
5.1%Current Dividend Yield
Is 4121 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 4121?
Other financial metrics that can be useful for relative valuation.
|What is 4121's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 4121's PE Ratio compare to its peers?
|4121 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
4138 Dynamic Medical Technologies
4106 Apex Medical
6797 Taiwan Advanced Nanotech
4161 Bioptik Technology Incorporation
4121 Rossmax International
Price-To-Earnings vs Peers: 4121 is good value based on its Price-To-Earnings Ratio (15.4x) compared to the peer average (24.8x).
Price to Earnings Ratio vs Industry
How does 4121's PE Ratio compare vs other companies in the TW Medical Equipment Industry?
Price-To-Earnings vs Industry: 4121 is good value based on its Price-To-Earnings Ratio (15.4x) compared to the TW Medical Equipment industry average (20.5x)
Price to Earnings Ratio vs Fair Ratio
What is 4121's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||15.4x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 4121's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 4121 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 4121 (NT$21.5) is trading below our estimate of fair value (NT$23.13)
Significantly Below Fair Value: 4121 is trading below fair value, but not by a significant amount.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Rossmax International forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Rossmax International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine whether Rossmax International is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
How has Rossmax International performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4121 has high quality earnings.
Growing Profit Margin: 4121's current net profit margins (2.8%) are lower than last year (4.6%).
Past Earnings Growth Analysis
Earnings Trend: 4121's earnings have grown significantly by 34.1% per year over the past 5 years.
Accelerating Growth: 4121's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4121 had negative earnings growth (-35.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (19%).
Return on Equity
High ROE: 4121's Return on Equity (8.8%) is considered low.
Discover strong past performing companies
How is Rossmax International's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 4121's short term assets (NT$2.4B) exceed its short term liabilities (NT$1.4B).
Long Term Liabilities: 4121's short term assets (NT$2.4B) exceed its long term liabilities (NT$934.7M).
Debt to Equity History and Analysis
Debt Level: 4121 has more cash than its total debt.
Reducing Debt: 4121's debt to equity ratio has reduced from 24.4% to 16.4% over the past 5 years.
Debt Coverage: 4121's debt is well covered by operating cash flow (151.7%).
Interest Coverage: 4121's interest payments on its debt are well covered by EBIT (11.4x coverage).
Discover healthy companies
What is Rossmax International current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 4121's dividend (5.12%) is higher than the bottom 25% of dividend payers in the TW market (2.46%).
High Dividend: 4121's dividend (5.12%) is low compared to the top 25% of dividend payers in the TW market (6.73%).
Stability and Growth of Payments
Stable Dividend: 4121 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 4121's dividend payments have increased, but the company has only paid a dividend for 9 years.
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (78.4%), 4121's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (29%), 4121's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Chih-Ping Liu serves as Chairman and General Manager of Rossmax International Ltd. and has been its Director since December 13, 1988. Mr. Liu serves as Chairman of ROSSMAX medical electronics Shanghai...
Experienced Board: 4121's board of directors are considered experienced (4.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Rossmax International Ltd.'s employee growth, exchange listings and data sources
- Name: Rossmax International Ltd.
- Ticker: 4121
- Exchange: TPEX
- Founded: 1988
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: NT$1.826b
- Shares outstanding: 84.93m
- Website: https://www.rossmax.com
- Rossmax International Ltd.
- No. 189, Kang Chien Road
- 12th Floor
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|4121||TPEX (Taipei Exchange)||Yes||Common Stock||TW||TWD||Jul 2003|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/09/25 00:00|
|End of Day Share Price||2022/09/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.